Piper Jaffray Downgrades Vitae Pharmaceuticals (VTAE) to Neutral

September 20, 2016 1:37 PM EDT
Get Alerts VTAE Hot Sheet
Price: $21.00 --0%

Rating Summary:
    1 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade VTAE Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Piper Jaffray downgraded Vitae Pharmaceuticals (NASDAQ: VTAE) from Overweight to Neutral.

For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.

Shares of Vitae Pharmaceuticals closed at $20.85 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Piper Jaffray

Add Your Comment